These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 20408551)
21. Short term treatment with St. John's wort, hypericin or hyperforin fails to induce CYP450 isoforms in the Swiss Webster mouse. Bray BJ; Brennan NJ; Perry NB; Menkes DB; Rosengren RJ Life Sci; 2002 Feb; 70(11):1325-35. PubMed ID: 11883710 [TBL] [Abstract][Full Text] [Related]
22. Mechanism of action of St John's wort in depression : what is known? Butterweck V CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192 [TBL] [Abstract][Full Text] [Related]
23. Hyperforin as a possible antidepressant component of hypericum extracts. Chatterjee SS; Bhattacharya SK; Wonnemann M; Singer A; Müller WE Life Sci; 1998; 63(6):499-510. PubMed ID: 9718074 [TBL] [Abstract][Full Text] [Related]
24. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG). Dimpfel W; Schober F; Mannel M Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945 [TBL] [Abstract][Full Text] [Related]
25. [Formulation of St. John's wort extract. A medicinal obstacle course]. Schmidt PC Pharm Unserer Zeit; 2003; 32(3):203-11. PubMed ID: 12784540 [No Abstract] [Full Text] [Related]
26. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures. Komoroski BJ; Parise RA; Egorin MJ; Strom SC; Venkataramanan R Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6972-9. PubMed ID: 16203790 [TBL] [Abstract][Full Text] [Related]
27. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Moore LB; Goodwin B; Jones SA; Wisely GB; Serabjit-Singh CJ; Willson TM; Collins JL; Kliewer SA Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7500-2. PubMed ID: 10852961 [TBL] [Abstract][Full Text] [Related]
28. Determination of total hypericins in St. John's wort and herbal medicinal products. Anyzewska M; Kowalczuk A; Łozak A; Jabłczyńska R; Fijałek Z Acta Pol Pharm; 2010; 67(6):586-92. PubMed ID: 21229872 [TBL] [Abstract][Full Text] [Related]
29. St John's wort: Prozac from the plant kingdom. Di Carlo G; Borrelli F; Ernst E; Izzo AA Trends Pharmacol Sci; 2001 Jun; 22(6):292-7. PubMed ID: 11395157 [TBL] [Abstract][Full Text] [Related]
30. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Komoroski BJ; Zhang S; Cai H; Hutzler JM; Frye R; Tracy TS; Strom SC; Lehmann T; Ang CY; Cui YY; Venkataramanan R Drug Metab Dispos; 2004 May; 32(5):512-8. PubMed ID: 15100173 [TBL] [Abstract][Full Text] [Related]
31. Comparison of German St. John's wort products according to hyperforin and total hypericin content. Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilavecz M J Am Pharm Assoc (Wash); 2001; 41(4):560-6. PubMed ID: 11486982 [TBL] [Abstract][Full Text] [Related]
32. Drug interactions with St John's wort : mechanisms and clinical implications. Mannel M Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151 [TBL] [Abstract][Full Text] [Related]
33. Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines. Hostanska K; Reichling J; Bommer S; Weber M; Saller R Eur J Pharm Biopharm; 2003 Jul; 56(1):121-32. PubMed ID: 12837490 [TBL] [Abstract][Full Text] [Related]
34. Involvement of serotoninergic 5-HT1A/2A, alpha-adrenergic and dopaminergic D1 receptors in St. John's wort-induced prepulse inhibition deficit: a possible role of hyperforin. Tadros MG; Mohamed MR; Youssef AM; Sabry GM; Sabry NA; Khalifa AE Behav Brain Res; 2009 May; 199(2):334-9. PubMed ID: 19136030 [TBL] [Abstract][Full Text] [Related]
35. Effects of the antidepressant St. John's wort (Hypericum perforatum) on rat and human vas deferens contractility. Capasso R; Borrelli F; Montanaro V; Altieri V; Capasso F; Izzo AA J Urol; 2005 Jun; 173(6):2194-7. PubMed ID: 15879886 [TBL] [Abstract][Full Text] [Related]
36. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line. Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577 [TBL] [Abstract][Full Text] [Related]
37. Batch-to-batch reproducibility of St. John's wort preparations. Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilovecz M Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S152-6. PubMed ID: 11518067 [TBL] [Abstract][Full Text] [Related]
38. Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Russo E; Scicchitano F; Whalley BJ; Mazzitello C; Ciriaco M; Esposito S; Patanè M; Upton R; Pugliese M; Chimirri S; Mammì M; Palleria C; De Sarro G Phytother Res; 2014 May; 28(5):643-55. PubMed ID: 23897801 [TBL] [Abstract][Full Text] [Related]
39. Effect of eluent pH on the HPLC-UV analysis of hyperforin from St. John's Wort (Hypericum perforatum L.). Fourneron JD; Naït-Si Y Phytochem Anal; 2006; 17(2):71-7. PubMed ID: 16634282 [TBL] [Abstract][Full Text] [Related]
40. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway. Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]